By Beatrice Davis and Amelia Hunt
Government and Politics
On October 2nd, President Donald Trump announced to the nation via Twitter that he had tested positive for coronavirus after the first presidential debate on September 29th. To monitor the President’s relatively mild symptoms, he was flown to Walter Reed Medical Center where he was treated by some of the top doctors in America. This coming after more than 7.5 million cases and 214 thousand deaths of coronavirus in the United States. Now claiming he is “immune”, Trump plans this week to hold rallies in several swing states hoping to persuade undecided voters for the 2020 election.
Prime Minister, Jacinda Ardern, pledged that all energy generation in New Zealand will be 100% renewable by 2030.
Scientists, Emmanuelle Charpentier and Jennifer Doudna have won the Nobel Peace Prize in Chemistry after discovering the Crispr-Cas9 genome editing tool which could help treat inherited illnesses.
Due to animals being separated from their owners during the numerous hurricanes that have stricken the Gulf Coast, Mckamey Animal Shelter is at full capacity and highly encourages Chattanoogans to adopt. This Thursday, all adoption fees are waived, and no appointments are required. If more pets are not adopted soon, McKamey says, they, “wouldn’t be able to go help an impacted area because we don’t have space.”
Science and Technology
SpaceX and Nasa’s Crew-1 Dragon launch, which was scheduled for October 31st, has now been moved to at least early or mid-November. Nasa and SpaceX had concerns over a Falcon 9 rocket, which had been behaving strangely during a previous private flight. This mission’s historical importance lies in the fact that this is Nasa’s first mission using a privately made, human-occupied capsule.
While the second trial of Johnson & Johnson’s COVID vaccine is underway, it has been put on hold for the time being because a participant contracted an unexplained illness. While this is relatively common, especially in large medical trials, the company said it wanted to monitor the illness before doing any further testing. A request for the patient’s symptoms was declined to protect their privacy. This comes just weeks after AstraZeneca announced their vaccine trial had been put on hold because 2 patients developed a neurological condition.